Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer
Pallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez · 2025
Read Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer by Pallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732757.txt.
Description
Pallavi Nayak and co-authors review hormone targeted treatment for ovarian cancer in a 2025 paper, based on the head byline. Ovarian cancer stays among the deadliest cancers of women, and better targeted options are needed. A hormone receptor tied to reproduction appears on most ovarian tumors, which makes it a hook for guided drug delivery.
The search covered work from 2000 to 2025 across four databases, splitting peptide drug carriers from nanoparticle systems. In lab and animal studies the guided drugs slowed tumor growth strongly and entered cells several fold better, with less body wide harm. Early human studies, though small, showed response or control in about half of patients.
Catalog record
| CREATOR | Pallavi Nayak, Michela Varani, Anna Giorgio, Giuseppe Campagna, Donatella Caserta, Alberto Signore, Rafael Coveñas Rodríguez |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |